Familial hypercholesterolemia, a narrative review, part 1: definition and burden

FH 1: Definition and burden

Hypertension and Hyperlipidemia Academy 5, a hybrid event

5th session of H&H Academy, online and onsite

Save the date: A glimpse of DCS 1400 and invitation to DCS 1401

DCS 1400 review and what’s coming next

Umbrella Heart and Stroke: session 2, carotid stenosis and stroke

Umbrella H&S: session 2, carotid stenosis

Hypertension and Hyperlipidemia Academy: 4th session

H&H Academy session 4

Save the date: H&H Academy 5th session

H&H Academy session 5

Save the date: Daily Cardiology Symposium 1401

DCS 1401 save the date poster

Cardiometabolic Grand round, Session 5

The 5th session of Cardiometabolic grand round

Save the date: Hypertension and hyperlipidemia academy, session 4

The 4th session of Hypertension and hyperlipidemia academy

Save the date: Umbrella: Heart and Stroke

The second program of Umbrella series: Heart and Stroke

Save the date: Cardiometabolic grand round, 5th session

The 5th session of Cardiometabolic grand round program

Primary prevention in dyslipidemia as the only cardiovascular risk factor

Dyslipidemia in primary prevention of low-risk patients

Late-breaking Science in Cardiovascular disease prevention

ESC 2021 cardiovascular prevention guideline lectures and discussion

Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session

The 4th session of Cardiorenal metabolic crossroads program

Management of dyslipidemia in diabetic patients

DLP and T2DM: approach and management

DiaBeat: The Beating Heart of Diabetes (8th session)

8th Diabetes Masterclass for Cardiologists

Save the date: Late-breaking Science in Cardiovascular disease prevention

ESC 2021 cardiovascular prevention guideline lectures and discussion

Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion

The second session of Cardiorenal metabolic crossroads program

Save the date; DiaBeat: The Beating Heart of Diabetes

8th Diabetes Masterclass for Cardiologists

Landmark trials of ESC 2021 congress

2021 post-ESC headlines

Cardiopoint 13: Management of stage 1 hypertension in adults with low cardiovascular risk

Stage 1 HTN in low risk patients

Cardio-Watch Podcast: Episode 7, ESC 2021 special

The seventh episode of Cardio-Watch: ESC 2021

Save the date: 2021 post ESC Headlines

Ground-breaking research from ESC 2021

Umbrella: Focused Cardiology Forum, Chronic Coronary Syndrome

Umbrella: CCS

Umbrella: CCS, Scientific program

The scientific program of Umbrella: CCS event

The clinical landscape for Diabetes and Cardiovascular disease

T2DM and cardiovascular diseases: The clinical landscape

Introducing the Umbrella CCS event

Umbrella CCS is underway

Long-term event-free and overall survival with Dapagliflozin in HFrEF patients

Impact of Dapagliflozin on the survival of HFrEF patients

DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate

7th Diabetes Masterclass for Cardiologists

From optimal medical therapy to revascularization in CCS

Choosing the best therapeutic strategy in CCS

Save the date: The first Umbrella event: chronic coronary syndrome

First Umbrella session: CCS

Finding the optimal thromboprophylaxis regimen in patients with COVID-19

Preventing thromboembolic events in COVID-19

Umbrella: focused cardiology forums

New series by Daily Cardiology Academy: Umbrella

Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD

7th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention

Save the date: Umbrella, Focused cardiology forums

The first session of Umbrella series

Tailored Antithrombotic therapy for CCS patients

Best individual antithrombotic strategy in CCS

Cardio-Watch Podcast: Episode 5, cardiometabolic disorders

The fifth episode of Cardio-Watch: cardiometabolic disorders

Marking the antiplatelet therapy maze in ACS

How to prevent atherosclerotic cardiovascular events

Cardio-Watch Podcast: Episode 4, Dyslipidemia

The fourth episode of Cardio-Watch: Dyslipidemia

DiaBeat: The Beating Heart of Diabetes (6th session)

6th Diabetes Masterclass for Cardiologists

Cardiometabolic Grand Round: 4th session

Guideline-directed cardiovascular evaluations before surgery

Cardiovascular complications of T2DM: the preventive role of SGLT2Is

SGLT2Is and the prevention of cardiovascular complications in T2DM

DCS 1400: session 2, Diabetes for cardiologists

The second panel of DCS 1400: diabetes for cardiologists

DCS 1400: session 1, HTN and DLP

The first panel of DCS 1400: hypertension and dyslipidemia

DCS 1400: welcome remarks

The initial greetings of DCS 1400

Save the date: Diabetes On Target (DOT): the latest updates

Save the date; DiaBeat: The Beating Heart of Diabetes

6th Diabetes Masterclass for Cardiologists

Save the date: Cardiometabolic Grand Round 4th session

The fourth session of Cardiometabolic grand round

How to reduce the atherosclerotic cardiovascular risk

A case-based Review on HTN and DLP management

Updates on the management of Diabetes and cardiometabolic disease

Actoverco Diabetes Lunch Webinar

Cardio-Watch Podcast: Episode one; COVID-19 and the heart

The first episode of Cardio-Watch podcast

The evolution of antiplatelet therapy in CAD: a 45 year journey

A brief history of anti-platelet therapy in CAD

Dual antiplatelet therapy in2021: Current recommendations

The latest updates on DAPT

Impact: the paradox of physical activity in cardiovascular disease

The contemporary Copenhagen general population study

DiaBeat: The Beating Heart of Diabetes (5th session)

5th Diabetes Masterclass for Cardiologists

Save the date: Abidi Hypertension and Hyperlipidemia Academy

Keeping up-to-date on HTN and DLP treatment

Self-measured blood pressure monitoring at home

What to teach the patients about recording their blood pressure themselves

DiaBeat: The Beating Heart of Diabetes (4th session)

4th Diabetes Masterclass for Cardiologists

DiaBeat: The Beating Heart of Diabetes (3rd session)

3rd Diabetes Masterclass for Cardiologists

DiaBeat: The Beating Heart of Diabetes (2nd session)

2nd Diabetes Masterclass for Cardiologists

DiaBeat: The Beating Heart of Diabetes (1st session)

1st Diabetes Masterclass for Cardiologists

Daily Cardiology Symposium 1400. Concise, Precise, Practical

Case-based review of common cardiovascular practice The digital experience

PCSK9 inhibitors place in patients with cardiometabolic diseases

PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist

Save the date: Daily Cardiology Symposium 1400

Case-based review of common cardiovascular practice

Impact: Statin treatment and muscle symptoms

StatinWise Trial

Cardiometabolic Grand Round (3)

A brief talk on DM medication challenges in patients with CVD

An introduction to daily cardiology academy symposium; a digital learning opportunity

Invitation for attending the symposium by executive directors

Save the date; DiaBeat: The Beating Heart of Diabetes

4th Diabetes Masterclass for Cardiologists

CardioPoint (10): The growing burden of cardiovascular diseases

Emphasizing the importance of CVD prevention and management

Save the date; DiaBeat: The Beating Heart of Diabetes

3rd Diabetes Masterclass for Cardiologists

Introduction: Evolution of DOACs and their place in Guidelines

A brief report of Guidelines mentioned DOACs place in practice

Save the date: To DOAC or Not To DOAC

Rapid review of oral Anticoagulation practice in different clinical scenarios

To DOAC or Not to DOAC

Rapid review of oral anticoagulation practice in different clinical scenarios

9th Case: Renal Insufficiency

OAC Management in Patients with CKD

Save the date: 1st Daily Cardiology Symposium

Case-based review of common cardiometabolic practice

Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

SGLT2 inhibitors in the treatment of HF: the future is bright?

Cardiologist Perspective on SGLT2 inhibitors

SGLT2 inhibition: A snapshot into their evolution

Endocrinologist Perspective on SGLT2 inhibitors

SGLT2 inhibition: Making waves in the heart failure landscape

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

Residents’ Island: Abidi CVD Prevention Academy

Multidisciplinary approach to CVD Prevention

Save the date: Residents’ Island; Abidi CVD Prevention Academy

Multidisciplinary approach to CVD Prevention

Save the date: SGLT2 inhibition: Making waves in the heart failure landscape

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

Save the date: Cardiometabolic Grand Round (2)

A brief talk on DM medication challenges in patients with CVD

Impact: EMPA-RESPONSE-AHF

Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)

Cardiometabolic Grand Round (2)

A brief talk on DM medication challenges in patients with CVD

A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)

A quick review on the findings of TIPS-3 trial from AHA congress 2020

The role of Omega 3 and Vitamin D in the Primary Prevention of AF (VITAL-RHYTHM Trial)

Dietary Supplements and AF

Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)

The Important findings of SCORED trial from AHA 2020 congress in brief

Effects of Evolocumab on Complex Coronary Disease Requiring Revascularization

Evolocumab in the pipeline

Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)

Sotagliflozin in T2DM and exacerbated HF

Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)

Iron supplementation in acute heart failure

Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes

Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD

Treatment goals for LDL cholesterol across categories of total CV risk

Overview of 2019 ESC/EAS Guidelines for the management of dyslipidemia

Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)

Finerenone protecting kidneys

Save the date: Cardiometabolic Grand Round

A brief talk on DM management in patients with CVD

Cardiometabolic Grand Round (1)

A brief talk on DM management in patients with CVD

Monitor eGFR in Patients Treated with Metformin

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Glycemic Management for patients with T2DM and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD